Biomarkers for Alzheimer's disease: ready for the next step.
作者信息
Rosenberg Paul B, Hillis Argye E
机构信息
Psychiatry and Behavioral Sciences, Division of Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, 5300 Alpha Commons Drive, AC4 Baltimore, MD 21224, USA.
出版信息
Brain. 2009 Aug;132(Pt 8):2002-4. doi: 10.1093/brain/awp184. Epub 2009 Jul 16.
Abstract
摘要
相似文献
1
Biomarkers for Alzheimer's disease: ready for the next step.阿尔茨海默病的生物标志物：准备好迈向下一步了。
Brain. 2009 Aug;132(Pt 8):2002-4. doi: 10.1093/brain/awp184. Epub 2009 Jul 16.
2
Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.阿尔茨海默病神经影像倡议中生物标志物、认知标志物和风险因素组合对预测轻度认知障碍患者向阿尔茨海默病转化的效用
Arch Gen Psychiatry. 2011 Sep;68(9):961-9. doi: 10.1001/archgenpsychiatry.2011.96.
3
Alzheimer's disease biomarkers: their value in diagnosis and clinical trials.阿尔茨海默病生物标志物：它们在诊断和临床试验中的价值。
Front Biosci. 2002 Apr 1;7:d986-8. doi: 10.2741/A824.
4
Metrifonate for Alzheimer's disease patients.
J Clin Psychiatry. 2000 Mar;61(3):218-9. doi: 10.4088/jcp.v61n0312d.
5
Cognitive profiles in Alzheimer's disease.阿尔茨海默病的认知特征。
J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):4-5.
6
Taking the next steps in the diagnosis of Alzheimer's disease: the use of biomarkers.推进阿尔茨海默病的诊断：生物标志物的应用
CNS Spectr. 2008 Mar;13(3 Suppl 3):7-10. doi: 10.1017/s1092852900017193.
7
Antipsychotics, cognitive decline and death in Alzheimer's disease: the London and South-East Region Alzheimer's Disease longitudinal study.抗精神病药物、阿尔茨海默病中的认知衰退与死亡：伦敦及东南部地区阿尔茨海默病纵向研究
J Neurol Neurosurg Psychiatry. 2007 Jan;78(1):2. doi: 10.1136/jnnp.2006.100586.
8
[Before dementia--early features in Alzheimer's disease].
Duodecim. 1998;114(1):21-30.
9
Comparison table: drugs for Alzheimer's disease.比较表：用于治疗阿尔茨海默病的药物。
Med Lett Drugs Ther. 2017 Sep 25;59(1530):e160-e161.
10
Alzheimer's disease.阿尔茨海默病
BMJ. 1993 Sep 25;307(6907):779-82. doi: 10.1136/bmj.307.6907.779.
引用本文的文献
1
Widespread white matter degeneration preceding the onset of dementia.在痴呆症发作之前广泛的白质退化。
Alzheimers Dement. 2015 May;11(5):485-493.e2. doi: 10.1016/j.jalz.2014.04.518. Epub 2014 Jul 14.
2
Regions of interest computed by SVM wrapped method for Alzheimer's disease examination from segmented MRI.SVM 包裹法计算感兴趣区域，用于从分割 MRI 检查阿尔茨海默病。
Front Aging Neurosci. 2014 Feb 20;6:20. doi: 10.3389/fnagi.2014.00020. eCollection 2014.
3
Cerebrospinal fluid and blood biomarkers in Alzheimer's disease.阿尔茨海默病的脑脊液和血液生物标志物。
World J Psychiatry. 2011 Dec 31;1(1):8-18. doi: 10.5498/wjp.v1.i1.8.
4
Harnessing neuroplasticity for clinical applications.利用神经可塑性进行临床应用。
Brain. 2011 Jun;134(Pt 6):1591-609. doi: 10.1093/brain/awr039. Epub 2011 Apr 10.
本文引用的文献
1
Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease.从遗忘型轻度认知障碍到阿尔茨海默病的脑代谢纵向变化。
Brain. 2009 Aug;132(Pt 8):2058-67. doi: 10.1093/brain/awp132. Epub 2009 May 28.
2
Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease.自动化磁共振成像测量可识别出患有轻度认知障碍和阿尔茨海默病的个体。
Brain. 2009 Aug;132(Pt 8):2048-57. doi: 10.1093/brain/awp123. Epub 2009 May 21.
3
Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve.利用皮质厚度进行阿尔茨海默病的早期诊断：认知储备的影响
Brain. 2009 Aug;132(Pt 8):2036-47. doi: 10.1093/brain/awp105. Epub 2009 May 12.
4
Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.正常老年人中阿尔茨海默病样萎缩模式的纵向进展：SPARE-AD指数
Brain. 2009 Aug;132(Pt 8):2026-35. doi: 10.1093/brain/awp091. Epub 2009 May 4.
5
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.发作性记忆丧失与老年受试者海马介导的β-淀粉样蛋白沉积有关。
Brain. 2009 May;132(Pt 5):1310-23. doi: 10.1093/brain/awn320. Epub 2008 Nov 28.
6
IL-6 release by LPS-stimulated peripheral blood mononuclear cells as a potential biomarker in Alzheimer's disease.脂多糖刺激的外周血单核细胞释放白细胞介素-6作为阿尔茨海默病的潜在生物标志物。
Int Psychogeriatr. 2009 Apr;21(2):413-4. doi: 10.1017/S1041610208008107. Epub 2008 Dec 1.
7
Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease.外周β淀粉样蛋白亚型作为阿尔茨海默病的风险生物标志物。
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14052-7. doi: 10.1073/pnas.0805902105. Epub 2008 Sep 8.
8
Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.使用阿尔茨海默病神经影像倡议数据库验证心室扩大作为阿尔茨海默病进展的一种可能指标。
Brain. 2008 Sep;131(Pt 9):2443-54. doi: 10.1093/brain/awn146. Epub 2008 Jul 11.
9
Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.评估血浆 Abeta(40) 和 Abeta(42) 作为轻度认知障碍患者向阿尔茨海默病转化的预测因子。
Neurobiol Aging. 2010 Mar;31(3):357-67. doi: 10.1016/j.neurobiolaging.2008.03.027. Epub 2008 May 19.
10
Serum sphingomyelins and ceramides are early predictors of memory impairment.血清神经酰胺和神经鞘磷脂是记忆障碍的早期预测指标。
Neurobiol Aging. 2010 Jan;31(1):17-24. doi: 10.1016/j.neurobiolaging.2008.03.011. Epub 2008 May 5.
Zotero 插件